Form 8-K - Current report:
SEC Accession No. 0001437749-25-017989
Filing Date
2025-05-21
Accepted
2025-05-21 16:20:34
Documents
15
Period of Report
2025-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K aytu20250515_8k.htm   iXBRL 8-K 46818
2 EXHIBIT 10.1 ex_820825.htm EX-10.1 8364
7 logo01.jpg GRAPHIC 3651
  Complete submission text file 0001437749-25-017989.txt   203333

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA aytu-20250521.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20250521_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20250521_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20250521_pre.xml EX-101.PRE 12022
17 EXTRACTED XBRL INSTANCE DOCUMENT aytu20250515_8k_htm.xml XML 2947
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 25973416
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)